Author: Hugh Gosling

In the wake of a sharp decline in sales of its blockbuster arthritis drug, Remicade, Merck & Co – known as MSD in the UK – is to offer the NHS discounts and rebates amounting to £48 million on £191 million sales, announced medical affairs director Colin Wheeler last week.

In the wake of a sharp decline in sales of its blockbuster arthritis drug, Remicade, Merck is to offer the NHS discounts and rebates amounting to £48 million on £191 million sales, announced medical affairs director Colin Wheeler last week.

The largest study of the genetics of testicular germ cell tumours has uncovered four new genetic variants associated with increased risk of testicular cancer – the most common cancer in young men.